Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22
Authors:
Open Access
- 7 August 2024
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (10) , 4312-4328
Abstract
No abstract availableKeywords
Funding Information
- Shanghai University of Traditional Chinese Medicine (2023YZZ02)
- National Natural Science Foundation of China (82374086)
- National Natural Science Foundation of China (82104459)
- National Natural Science Foundation of China (82141203)
- National Key Research and Development Program of China (2022YFC3502000)
- Science and Technology Commission of Shanghai Municipality (20YF1458700)
- Science and Technology Commission of Shanghai Municipality (ZD2021CY001)
- Chinese Academy of Sciences
This publication has 58 references indexed in Scilit:
- Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolismActa Pharmaceutica Sinica B, 2022
- The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentationActa Pharmaceutica Sinica B, 2021
- A comparative study of Mesenchymal Stem Cells transplantation approach to antagonize age-associated ovarian hypofunction with consideration of safety and efficiencyJournal of Advanced Research, 2021
- Ubiquitin-specific peptidase 22 in cancerCancer Letters, 2021
- Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTORActa Pharmaceutica Sinica B, 2021
- Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5Acta Pharmaceutica Sinica B, 2020
- Small-Molecule Targets in Immuno-OncologyCell Chemical Biology, 2017
- Deubiquitination and Stabilization of PD-L1 by CSN5Cancer Cell, 2016
- Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating EnzymesChemistry & Biology, 2011
- Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancerJournal of Surgical Oncology, 2010